Location History:
- Lausanne, CH (2017 - 2019)
- Saint Sulpice, CH (2021)
Company Filing History:
Years Active: 2017-2021
Title: Innovations by Rodrigo Araujo Fraga Da Silva
Introduction
Rodrigo Araujo Fraga Da Silva is a notable inventor based in Saint-Sulpice, Switzerland. He has made significant contributions to the field of electro-stimulation systems, particularly in the rehabilitation and treatment of sexual disorders. With a total of four patents to his name, his work is at the forefront of medical technology.
Latest Patents
One of his latest patents involves an implantable stimulation system designed to selectively stimulate at least one cavernous nerve. This system includes an implantable stimulation unit coupled to a programmable controller, a stimulation circuit, and an array of electrodes on flexible paddles. The programmable controller is pre-programmed to execute an excitation electrode routine that scans the electrode arrays with directional current flows. This optimization enhances the selection of electrodes for effective stimulation of the cavernous nerve. The system can be programmed to run various stimulation modes, including a rapid erectile response mode, a nerve rehabilitation mode, and a penile rehabilitation mode aimed at reducing penile fibrosis. Methods for operating this advanced system are also included in the patent.
Career Highlights
Rodrigo has worked with prestigious organizations such as École Polytechnique Fédérale de Lausanne and Comphya SA. His experience in these institutions has contributed to his expertise in developing innovative medical technologies.
Collaborations
Throughout his career, Rodrigo has collaborated with notable professionals, including Nikolaos Stergiopulos and Mikael Nils Sturny. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Rodrigo Araujo Fraga Da Silva is a pioneering inventor whose work in electro-stimulation systems is making a significant difference in medical treatments. His innovative patents and collaborations highlight his commitment to advancing healthcare technology.